FDA Approves Thermo Fisher CDx for Glioma Treatment with VORANIGO
Thermo Fisher’s CDx for identifying glioma patients eligible for treatment with Servier Pharmaceuticals’ VORANIGO gets FDA approval.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Unknown Origin & Other Cancer Types |
Thermo Fisher’s CDx for identifying glioma patients eligible for treatment with Servier Pharmaceuticals’ VORANIGO gets FDA approval.
Read MorePosted by Andy Lundin | Oct 16, 2024 | Diagnostic Technologies, POC Instruments |
A handheld, sound-based diagnostic system can deliver precise blood test results in under 70 minutes from a finger prick.
Read MorePosted by Chris Wolski | Oct 14, 2024 | Cervical (HPV) |
Labcorp’s adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
Read MorePosted by Chris Wolski | Oct 11, 2024 | Molecular Diagnostic Analyzers |
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Read MorePosted by Andy Lundin | Oct 11, 2024 | Sequencing Systems |
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read More